ArticleMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents2026
Proangiogenic effect and molecular mechanism of a new cytosporin derivative from the marine fungus Eutypella sp. D-1.
Article in Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
A new cytosporin derivative, cytoeutypellane D, was isolated from a culture extract of the Arctic-derived fungus Eutypella sp. D-1. Its structure was determined based on a detailed nuclear magnetic resonance spectroscopic interpretation, a mass spectrometry data analysis, and a literature review. Zebrafish were used in in vivo experiments to discover that the isolated compound significantly promoted angiogenesis in a dose-dependent manner. Further studies regarding the underlying mechanisms revealed that it may target the VEGF/VEGFR2 signaling pathway and rescue abnormal expressions of the cdk1, aurkb, topbp1, and brca2 genes to improve vascular endothelial cell proliferation and migration in zebrafish. In summary, our findings suggested that this novel compound isolated from the fungus Eutypella sp. D-1 might be used as a promising molecule for vascular injury disease treatment.
Indexed as
Identifiers
42446555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.